EXECUTIVE ENGAGEMENTS
OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPETITORS
* Login for a full stack data experience
DATE
APR 2021
TABLES
210
PAGES
333
EDITION
20
PRICE
USD $5450
HIGHLIGHTS
SELECT PLAYERS
Agilent Technologies, Inc.; Becton, Dickinson and Company; Fluidigm Corporation; Illumina Inc.; Oxford Gene Technology; Oxford Nanopore Technologies; Pacific Biosciences of California Inc.; QIAGEN N.V.; RainDance Technologies Inc.; Roche Sequencing; Thermo Fischer Scientific Inc.
SEGMENTS
» Product Type (Consumables, Platforms, Services) » Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Next Generation Sequencing Techniques Transform the Genomics Space |
Recent Market Activity |
Next Generation Sequencers (NGS): A High-Throughput Sequencing Technology |
US Leads the NGS Market, Asia-Pacific to Foster Future Growth |
Academic & Research Dominates NGS Market |
Oncology Testing - The Application with Most Promising Opportunities for NGS Technology |
Declining Cost of Sequencing to Fuel Adoption of NGS Systems |
After Dramatic Price Declines, Is NGS Market Positioned for Further Disruption? |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
Agilent Technologies Inc. (US) |
Becton, Dickinson and Company (BD) (US) |
Fluidigm Corporation (US) |
Genomatix GmbH (Germany) |
Illumina, Inc. (US) |
Oxford Gene Technology (UK) |
Oxford Nanopore Technologies (UK) |
Pacific Biosciences of California, Inc. (US) |
QIAGEN N.V. (The Netherlands) |
RainDance Technologies, Inc. (US) |
Roche Sequencing (US) |
Shenzhen BGI Diagnosis Co., Ltd. (China) |
Thermo Fisher Scientific, Inc. (US) |
3. MARKET TRENDS & DRIVERS |
Expanding Applications of NGS Technology |
NGS Revolutionizes Drug Discovery and Development Space |
Genetic Information offered by NGS Aids in Drug Development Process |
Revolutionary Capabilities of NGS Technology to Play a Vital Part in Advancement of Precision Medicine |
Rising Incidences of Cancer & Benefits of Personalized Cancer Therapy to Propel NGS Market |
Comparison of Sanger Sequencing, Real-time PCR Sequencing and Next Generation Sequencing Methods for Identification of Driver Mutations |
Key Cancer Statistics |
NGS Emerges as a Game Changing Technology for Precision Oncology |
Personalized Medicine: Growing Prominence of NGS in Providing Customized Treatments to Patients |
Growing Significance of NGS in Enabling Personalized Oncology - Timeline of Major Developments in Sequencing Technologies & Applications Related to Oncology |
Personal Genomics Services - Blessing or Bane? |
NGS Technology Drives RNA Sequencing in Transcriptomics |
Longer Reach of a Read: A Key Feature Considered for Sequencing |
qPCR - The Core Technique in NGS Technique |
Development of New Systems & Platforms to Fuel NGS Utilization |
Advancements in Next Generation Sequencing (NGS) Technology Fuel Adoption |
Development Efforts Intensify in Long-Read Sequencing |
Single-Cell Genomics: A Promising Application of NGS Technology |
Shift from Tumor Biopsies to Cancer Liquid Biopsies |
NGS Enhances Study of Antimicrobial Resistance |
Effective Use of NGS Tools in Public Healthcare Systems |
E-Infrastructure for Storage & Analysis of NGS Data |
Explosive Growth in Sequencing Data Drives Focus onto Cloud Computing |
NGS Hold an Edge Over CE Sequencing Method |
Standardization of NGS Technique: A Critical Requirement for Wider Adoption |
Challenges Confronting High-throughput Sequencing Market |
High Machine Costs and Licensure Fees |
Lack of Skilled Personnel |
Absence of Regulatory Framework |
Limited Access to Scientific Literature and Internet |
Suboptimal Outsourcing Services |
Regulations Related to NGS-Based Tests |
Innovative Technologies |
Nanopore Sequence Technology |
Single-Molecule Real-Time technology (SMRT) |
Direct Genomics’ Single Molecule Sequencing |
TruSPADES Simplifies Metagenomics Sequencing |
GnuBIO Platform |
Electron Microscopy DNA Sequencing |
FRET-based DNA Sequencing |
Identification/Sequencing using Mechanical Properties |
MALDI-TOF MS |
RNAP Sequencing Method |
Tunneling Currents DNA Sequencing |
qPCR-Driven Library Quantitation Saves Time and Overheads |
Achieving Trans-Block Uniformity |
Enhancing qPCR Precision |
4. GLOBAL MARKET PERSPECTIVE |
World Current & Future Analysis for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Biomarkers & Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Biomarkers & Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Biomarkers & Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
USA Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
USA Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
CANADA |
Canada Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Canada Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
JAPAN |
Japan Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Japan Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
CHINA |
China Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
China Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
EUROPE |
Europe Current & Future Analysis for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
FRANCE |
France Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
France Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
GERMANY |
Germany Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Germany Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
ITALY |
Italy Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Italy Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
UNITED KINGDOM |
UK Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
UK Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
SPAIN |
Spain Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Spain Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
RUSSIA |
Russia Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Russia Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
REST OF EUROPE |
Rest of Europe Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Rest of Europe Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
ASIA-PACIFIC |
Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
AUSTRALIA |
Australia Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Australia Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
INDIA |
India Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
India Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
India Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
India Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
SOUTH KOREA |
South Korea Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
South Korea Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Rest of Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
LATIN AMERICA |
Latin America Current & Future Analysis for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
Latin America Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Latin America Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
ARGENTINA |
Argentina Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Argentina Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Argentina 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Argentina Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Argentina Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Argentina 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
BRAZIL |
Brazil Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Brazil Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Brazil 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Brazil Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Brazil Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Brazil 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
MEXICO |
Mexico Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Mexico Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Mexico 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Mexico Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Mexico Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Mexico 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
REST OF LATIN AMERICA |
Rest of Latin America Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Latin America Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Latin America 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Rest of Latin America Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Latin America Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Latin America 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
MIDDLE EAST |
Middle East Current & Future Analysis for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
Middle East Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Middle East Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
IRAN |
Iran Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Iran Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Iran 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Iran Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Iran Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Iran 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
ISRAEL |
Israel Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Israel Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Israel 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Israel Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Israel Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Israel 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
SAUDI ARABIA |
Saudi Arabia Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Saudi Arabia Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Saudi Arabia 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Saudi Arabia Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Saudi Arabia Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Saudi Arabia 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
UNITED ARAB EMIRATES |
UAE Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UAE Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UAE 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
UAE Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UAE Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UAE 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
REST OF MIDDLE EAST |
Rest of Middle East Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Middle East Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Middle East 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Rest of Middle East Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Middle East Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Middle East 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
AFRICA |
Africa Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
Africa Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 93 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com